EMEA-002005-PIP01-16

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Amlodipine / atorvastatin

Decision numberP/0306/2016
PIP numberEMEA-002005-PIP01-16
Pharmaceutical form(s)Film-coated tablet
Condition(s)/indication(s)

Treatment of concomitant hypertension and dyslipidaemia

Treatment of concomitant angina and dyslipidaemia

Prevention of cardiovascular events in hypertension and diabetes mellitus type 2

Route(s) of administrationOral use
PIP applicant

ELPEN Pharmaceutical Co. Inc
Greece
Tel. +30 2106 039326
Fax +30 2106 039300
E-mail: info@elpen.gr

Decision typeW: decision granting a waiver in all age groups for all conditions/indications

Decision